Cowen analyst Ritu Baral raised the price target on Milestone Pharmaceuticals (NASDAQ: MIST) to $12.00 (from $6.00) while maintaining ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE